HGH-ALBO A/S — Credit Rating and Financial Key Figures

HGH-ALBO A/S (CVR number: 21594628) is a company from FURESØ. The company reported a net sales of 0.3 mDKK in 2024, demonstrating a decline of -0.8 % compared to the previous year. The operating profit percentage was at 30 % (EBIT: 0.1 mDKK), while net earnings were 91.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 4 %, which can be considered decent but Return on Equity (ROE) was 1.8 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 76.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. HGH-ALBO A/S's liquidity measured by quick ratio was 6.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.